Search research articles
Contact Us
Filters
Showing results (231-240 of 248) with videos related to
Page
of 25
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2018
Coamplification of <i>miR-4728</i> protects <i>HER2</i>-amplified breast cancers from targeted therapy
Konstantinos V Floros, Timothy L Lochmann, Bin Hu, et al.
Journal of Medicinal Chemistry
|
March 31, 2006
Screening for cardiovascular safety: a structure-activity approach for guiding lead selection of melanin concentrating hormone receptor 1 antagonists
Philip R Kym, Andrew J Souers, Thomas J Campbell, et al.
Cell Death & Disease
|
January 16, 2015
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
J D Leverson, H Zhang, J Chen, et al.
ACS Medicinal Chemistry Letters
|
June 20, 2014
Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL
Michael F T Koehler, Philippe Bergeron, Edna F Choo, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 14, 2007
Identification of diamino chromone-2-carboxamides as MCHr1 antagonists with minimal hERG channel activity
Andrew S Judd, Andrew J Souers, Dariusz Wodka, et al.
Journal of Medicinal Chemistry
|
May 2, 2015
Correction to Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity
Milan Bruncko, Le Wang, George S Sheppard, et al.
Journal of Medicinal Chemistry
|
February 14, 2015
Structure-guided design of a series of MCL-1 inhibitors with high affinity and selectivity
Milan Bruncko, Le Wang, George S Sheppard, et al.
Journal of Medicinal Chemistry
|
January 11, 2008
Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitor
Gang Zhao, Andrew J Souers, Martin Voorbach, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 26, 2006
Constrained 7-fluorocarboxychromone-4-aminopiperidine based Melanin-concentrating hormone receptor 1 antagonists: the effects of chirality on substituted indan-1-ylamines
Andrew J Souers, Rajesh R Iyengar, Andrew S Judd, et al.
Communications Medicine
|
October 25, 2023
Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients
Junichiro Yuda, Christine Will, Darren C Phillips, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 248) with videos related to
Sort By:
Page
of 25
Proceedings of the National Academy of Sciences of the United States of America
|
February 25, 2018
Coamplification of <i>miR-4728</i> protects <i>HER2</i>-amplified breast cancers from targeted therapy
Konstantinos V Floros, Timothy L Lochmann, Bin Hu, et al.
Journal of Medicinal Chemistry
|
March 31, 2006
Screening for cardiovascular safety: a structure-activity approach for guiding lead selection of melanin concentrating hormone receptor 1 antagonists
Philip R Kym, Andrew J Souers, Thomas J Campbell, et al.
Cell Death & Disease
|
January 16, 2015
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
J D Leverson, H Zhang, J Chen, et al.
ACS Medicinal Chemistry Letters
|
June 20, 2014
Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL
Michael F T Koehler, Philippe Bergeron, Edna F Choo, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 14, 2007
Identification of diamino chromone-2-carboxamides as MCHr1 antagonists with minimal hERG channel activity
Andrew S Judd, Andrew J Souers, Dariusz Wodka, et al.
Journal of Medicinal Chemistry
|
May 2, 2015
Correction to Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity
Milan Bruncko, Le Wang, George S Sheppard, et al.
Journal of Medicinal Chemistry
|
February 14, 2015
Structure-guided design of a series of MCL-1 inhibitors with high affinity and selectivity
Milan Bruncko, Le Wang, George S Sheppard, et al.
Journal of Medicinal Chemistry
|
January 11, 2008
Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitor
Gang Zhao, Andrew J Souers, Martin Voorbach, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 26, 2006
Constrained 7-fluorocarboxychromone-4-aminopiperidine based Melanin-concentrating hormone receptor 1 antagonists: the effects of chirality on substituted indan-1-ylamines
Andrew J Souers, Rajesh R Iyengar, Andrew S Judd, et al.
Communications Medicine
|
October 25, 2023
Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients
Junichiro Yuda, Christine Will, Darren C Phillips, et al.
Page
of 25